Dzana Dervovic

Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15

Junlin Yao, Dalam Ly, Dzana Dervovic et al. · Journal for ImmunoTherapy of Cancer · 2019 · 81 citations · Full text

Medicine, Immunology, Oncology +17

Development of a novel mouse model of amodiaquine-induced liver injury with a delayed onset

Imir G. Metushi, Ping Cai, Dzana Dervovic et al. · Journal of Immunotoxicology · 2014 · 43 citations

Veterinary Medicine, Immunology, Pharmacology +17

Notch signals are required for in vitro but not in vivo maintenance of human hematopoietic stem cells and delay the appearance of multipotent progenitors

Patricia Benveniste, Dzana Dervovic, Elaine Herer et al. · Blood · 2013 · 42 citations

Life Sciences, Developmental Biology, Hematology +17

In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer

Dzana Dervovic, Ahmad Malik, Edward L.Y. Chen et al. · Nature Communications · 2023 · 40 citations · Full text

Medicine, Cancer Biology, Oncology +17

Infusion of<i>ex-vivo</i>expanded human TCR-αβ+ double-negative regulatory T cells delays onset of xenogeneic graft-<i>versus</i>-host disease

Paulina Achita, Dzana Dervovic, Dalam Ly et al. · Clinical & Experimental Immunology · 2018 · 30 citations · Full text

Life Sciences, Cell Biology, Immunology +15